Genea Biomedx
Pioneering Fertility Technologies for Improved Patient Outcomes




Our company
Genea Biomedx is a global leader in comprehensive in vitro fertilisation (IVF) solutions, delivering innovative technologies to which empower patients to realise their dream of growing their family. Our cutting-edge devices enhance clinical outcomes by addressing variables like human error and environmental factors.
With user-friendly interfaces and automation, we boost efficiency and minimise errors. Through cutting-edge devices hosting intuitive interfaces and automated features, we provide consistent optimal clinical outcomes by increasing efficiency and reducing the risk of error. Committed to research and development, we set new industry standards. As a trusted partner, we provide exceptional customer service and support to laboratories worldwide, offering a holistic IVF solution for healthcare professionals and patients.
10
Million embryos monitored
600
Customers
70
Product certification
Milestones
Genea collaborates closely with embryologists, andrologists, clinicians, and nurses to consistently improve outcomes for clinics and their patients. During this time, we have designed and developed award-winning products, which now serve as the foundation for our continued global expansion and accelerated growth.

Genea Biomedx Values
At Genea Biomedx, our team operates with a core set of values which support our vision and shape our culture.
Our main values are:
A global IVF Leader
Continuous Innovation
Committed to Research
Trusted by Leading Healthcare Professionals
Personalised Service
Leadership Team

Peter Svalander
Genea Biomedx Board ChairmanPeter Svalander is a Medical Doctor and Associate Professor in Sweden, and a Board-certified Highcomplexity Clinical Laboratory Director (HCLD, ABB) in the USA. His extensive background in business start-ups, expansions, and technology includes roles as Founder/CEO of Vitrolife a world-leader in the field of fertility treatment and EHC a preventive cardiovascular diagnostic clinic, both in Sweden. Over the past 30 years he has held executive and medical positions in Sweden, USA, UK, Switzerland and Mauritius.

Teija Peura
Chief Scientific OfficerTeija Peura’s background is in academic science, with a PhD and post-doctoral roles in animal reproductive biotechnology in Finland and Australia. Since 2003, she has transitioned from the Sydney IVF/Genea R&D lab to leading Biomedx product development, then into business development, and eventually returning to a scientific role.

Tom Beckitt
Chief Operating OfficerTom Beckitt, with expertise in Biochemistry, Chemistry, and Clinical Trials, has extensive experience in the pharmaceutical, veterinary, and medical device industries in the UK and Australia. He specialises in drug discovery, vaccine development, and assisted reproductive technologies. Since joining Genea Biomedx in 2015, he has played a key role in the strategic growth and development of the company

Clara Pinto
Global Marketing and Communication DirectorClara is a global marketing and communications leader with over 15 years of experience in the healthcare and biotechnology sectors. With a background at IVI RMA Global and ATERSA Grupo Elecnor, she has led international marketing strategies across multiple regions. At Genea Biomedx, she drives brand positioning, scientific engagement, and digital innovation, working closely with R&D and product teams to support fertility specialists worldwide.

John Kwok
General Manager, Asia PacificJohn Kwok is a seasoned executive with over 15 years of leadership experience across the pharmaceutical, biotechnology, and medical-device industries. At Genea Biomedx, he leads the company’s Asia-Pacific operations, driving commercial strategy, market expansion, and operational excellence across the fertility technology landscape. John works closely with global and cross-functional teams to align regional priorities with innovation, R&D, and product development initiatives. Before joining Genea Biomedx, he held senior management roles at Abbott, Sanofi Genzyme, and MSD, where he built high-performing teams and delivered sustained growth across the Asia-Pacific region. John holds a BSc in Pharmacology from the University of Liverpool.

Heny Tang
Business Development DirectorWith a background in biotechnology and biomedical science, Heny is a dynamic and performance-driven professional with over a decade of experience in the global genomics and diagnostics landscape, with expertise especially in the APAC region. She expands our global footprint by building strategic global partnerships and penetrating new regional markets.
Our locations

Madrid
Genea Biomedx European Workshop
Edificio NET-Pharma Local 11 Carretera de Fuencarral, 22 Madrid, Spain

Hong Kong
Genea Biomedx APAC Head Office
A818 Room 601, 6/F, Tung Hip Commercial Building, 248 Des Voeux Road Central, Sheung Wan, Hong Kong ASR, China, Reg No.63648980

Valencia
Genea Biomedx European Head Office & Showroom
Ronda Guglielmo Marconi, 11 Edificio A 1º Paterna, Valencia, Spain

Sydney
Genea Biomedx Head Office and Product Development Center
321 Kent Street, Sydney, Australia
